FDA vs. CMS Mandates for Evaluating Novel MedTech

FDA vs. CMS Mandates for Evaluating Novel MedTech

FDA vs. CMS Mandates for Evaluating Novel MedTechNicole Coustier
Published on: 31/05/2024

FDA approval ensures safety and effectiveness—but CMS needs proof of clinical value. Here’s how to align your strategy with both mandates.

U.S. Healthcare Fundamentals